ACEA S.p.A. (ACEJF)
| Market Cap | 5.25B -2.4% |
| Revenue (ttm) | 3.19B +14.7% |
| Net Income | 568.76M +42.1% |
| EPS | 2.68 +42.1% |
| Shares Out | n/a |
| PE Ratio | 9.23 |
| Forward PE | 13.78 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 180 |
| Open | 23.30 |
| Previous Close | 22.25 |
| Day's Range | 23.30 - 23.30 |
| 52-Week Range | 17.95 - 23.30 |
| Beta | 0.89 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jul 23, 2026 |
About ACEA S.p.A.
ACEA S.p.A., together with its subsidiaries, operates as a multi-utility company in Italy. The company operates through Environment, Commercial, Water, Water (Overseas), Production, Engineering & Infrastructure Projects, and Network & Public Lighting segments. It is involved in the waste management, power generation, water management, energy distribution and production, gas distribution, management of engineering services, and sale of electricity and natural gas, as well as supplies value added environmental services. The company also generates... [Read more]
Financial Performance
In 2025, ACEA S.p.A.'s revenue was 2.76 billion, an increase of 0.29% compared to the previous year's 2.75 billion. Earnings were 480.58 million, an increase of 44.92%.
Financial numbers in EUR Financial StatementsNews
DCA raids pharma unit, seizes stocks worth ₹70L for tampering labels
Telangana DCA raided DK Pharmaceuticals in Alwal, seized ₹70.56 lakh excipient stock for alleged label tampering and fictitious manufacturing details.
DCA busts illegal sale of cardiac drug to gym-goers, seizes 38 vials in Warangal
Telangana DCA seized 38 vials of mephentermine sulphate injections in Warangal, allegedly sold illegally to gym-goers; officials warn of cardiac risks.
ACEA S.p.A. Slides: Investor presentation
ACEA S.p.A. has posted slides in relation to its latest quarterly earnings report, which was published on June 8, 2026.
DCA issues notices to 41 medical shops linked to online pharmacies over multiple violations
Telangana DCA issued show-cause notices to 41 medical shops linked to online pharmacies after inspecting 166 outlets and finding multiple violations statewide.
Telangana DCA raids medical shop for selling habit-forming drugs without prescription
Telangana DCA raids Ramanthapur medical shop, seizes codeine Tossex cough syrup and tramadol capsules for alleged illegal sale without prescriptions.
DCA raids medical shop for selling habit-forming drugs without prescription
Telangana DCA raids Ramanthapur medical shop, seizes codeine Tossex cough syrup and tramadol capsules for alleged illegal sale without prescriptions.
ACEA S.p.A. Earnings Call Transcript: Q1 2026
Q1 2026 saw strong growth in regulated businesses, with EBITDA up 4% and net income up 14% year-over-year. CapEx rose 18%, and guidance for 2026 is confirmed, supported by stable financials and ongoing investment in infrastructure.
ACEA S.p.A. Earnings release: Q1 2026
ACEA S.p.A. released its Q1 2026 earnings on May 14, 2026, summarizing the period's financial results.
ACEA S.p.A. Slides: Q1 2026
ACEA S.p.A. has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on May 14, 2026.
ACEA S.p.A. Quarterly report: Q1 2026
ACEA S.p.A. has published its Q1 2026 quarterly earnings report on May 14, 2026.
ACEA S.p.A. Slides: Investor presentation
ACEA S.p.A. has posted slides in relation to its latest quarterly earnings report, which was published on March 25, 2026.
ACEA S.p.A. Slides: Investor presentation
ACEA S.p.A. has posted slides in relation to its latest quarterly earnings report, which was published on March 13, 2026.
ACEA S.p.A. Earnings Call Transcript: Q4 2025
Record 2025 results with EBITDA up 10% and net profit up 49% year-over-year, driven by asset rotation, strong regulated business focus, and operational efficiency. Dividend rises 26% to €1.20 per share, including a one-off from asset disposals.
ACEA S.p.A. Earnings release: Q4 2025
ACEA S.p.A. released its Q4 2025 earnings on March 12, 2026, summarizing the period's financial results.
ACEA S.p.A. Slides: Q4 2025
ACEA S.p.A. has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on March 12, 2026.
ACEA S.p.A. Annual report: Q4 2025
ACEA S.p.A. has published its Q4 2025 annual report on March 12, 2026.
ACEA S.p.A. Slides: Investor presentation
ACEA S.p.A. has posted slides in relation to its latest quarterly earnings report, which was published on November 26, 2025.
ACEA S.p.A. Earnings Call Transcript: Q3 2025
Strong year-over-year growth in EBITDA and net profit, driven by regulated businesses and asset disposals. 2025 guidance raised, with continued focus on water, grids, and environment, and stable regulatory outlook. Asset rotation and financial discipline support future investments.
ACEA S.p.A. Earnings release: Q3 2025
ACEA S.p.A. released its Q3 2025 earnings on November 13, 2025, summarizing the period's financial results.
ACEA S.p.A. Slides: Q3 2025
ACEA S.p.A. has posted slides in relation to its Q3 2025 quarterly earnings report, which was published on November 13, 2025.
ACEA S.p.A. Quarterly report: Q3 2025
ACEA S.p.A. has published its Q3 2025 quarterly earnings report on November 13, 2025.
ACEA S.p.A. Slides: Investor presentation
ACEA S.p.A. has posted slides in relation to its latest quarterly earnings report, which was published on September 10, 2025.
ACEA S.p.A. Earnings Call Transcript: H1 2025
Strong H1 2025 results with double-digit EBITDA and net profit growth, driven by regulated businesses and strategic asset rotation. Upward guidance for 2025 reflects focus on infrastructure and improved financial profile.
ACEA S.p.A. Earnings release: H1 2025
ACEA S.p.A. released its H1 2025 earnings on July 24, 2025, summarizing the period's financial results.
ACEA S.p.A. Slides: H1 2025
ACEA S.p.A. has posted slides in relation to its H1 2025 quarterly earnings report, which was published on July 24, 2025.